| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 4 | 10 | 2009 | 2019 | ||||||||
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
disease | 0.440 | None | 1.000 | 1 | 10 | 2011 | 2020 | ||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 4 | 9 | 1999 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.430 | None | 1.000 | 2 | 9 | 2006 | 2019 | ||||||||
|
CUB and Sushi multiple domains 1 | 0.610 | 0.500 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 8 | 2011 | 2020 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.470 | None | 0.500 | 4 | 8 | 2002 | 2019 | ||||||||
|
reticulon 4 receptor | 0.595 | 0.692 | 0.96 |
|
disease | 0.670 | None | 0.857 | 3 | 7 | 2004 | 2017 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
disease | 0.410 | None | 1.000 | 2 | 7 | 2011 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 1 | 7 | 1996 | 2017 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.420 | None | 1.000 | 1 | 7 | 2010 | 2019 | ||||||||
|
serologically defined colon cancer antigen 8 | 0.619 | 0.577 | 1.2E-11 |
|
disease | 0.410 | None | 1.000 | 1 | 7 | 2011 | 2019 | ||||||||
|
zinc finger protein 804A | 0.647 | 0.654 | 5.5E-03 |
|
disease | 0.500 | None | 0.961 | 1 | 7 | 2008 | 2019 | ||||||||
|
VRK serine/threonine kinase 2 | 0.722 | 0.269 | 1.6E-11 |
|
disease | 0.480 | None | 1.000 | 2 | 6 | 2009 | 2019 | ||||||||
|
MIR137 host gene | 0.839 | 0.038 |
|
disease | 0.460 | None | 0.500 | 2 | 6 | 2011 | 2019 | |||||||||
|
t-SNARE domain containing 1 | 0.861 | 0.077 | 9.6E-07 |
|
disease | 0.440 | None | 1.000 | 1 | 6 | 2013 | 2019 | ||||||||
|
autophagy and beclin 1 regulator 1 | 0.729 | 0.308 | 1.00 |
|
disease | 0.420 | None | 1.000 | 1 | 6 | 2012 | 2019 | ||||||||
|
SET domain containing 1A, histone lysine methyltransferase | 0.619 | 0.615 | 1.00 |
|
disease | 0.650 | moderate | 1.000 | 2 | 5 | 2014 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.480 | None | 0.500 | 2 | 5 | 1993 | 2019 | ||||||||
|
calcium voltage-gated channel auxiliary subunit beta 2 | 0.659 | 0.538 | 2.7E-06 |
|
disease | 0.430 | None | 1.000 | 1 | 5 | 2013 | 2019 | ||||||||
|
epoxide hydrolase 2 | 0.568 | 0.654 | 1.8E-21 |
|
disease | 0.320 | None | 1.000 | 1 | 5 | 2016 | 2019 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.500 | None | 0.750 | 4 | 4 | 2000 | 2019 | ||||||||
|
glycoprotein M6A | 0.729 | 0.423 | 0.99 |
|
disease | 0.420 | None | 1.000 | 1 | 4 | 2008 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
disease | 0.400 | None | 0.600 | 5 | 3 | 2003 | 2020 | ||||||||
|
ankyrin 3 | 0.578 | 0.654 | 1.00 |
|
disease | 0.500 | None | 1.000 | 3 | 3 | 2009 | 2018 | ||||||||
|
cyclin and CBS domain divalent metal cation transport mediator 2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.450 | None | 1.000 | 2 | 3 | 2011 | 2019 |